These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25544397)

  • 41. Endothelin, renal diseases, and hypertension.
    Dussaule JC; Boffa JJ; Tharaux PL; Fakhouri F; Ardaillou R; Chatziantoniou C
    Adv Nephrol Necker Hosp; 2000; 30():281-303. PubMed ID: 11068648
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension.
    Ergul A
    Hypertension; 2000 Jul; 36(1):62-7. PubMed ID: 10904013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The endothelin system and its antagonism in chronic kidney disease.
    Dhaun N; Goddard J; Webb DJ
    J Am Soc Nephrol; 2006 Apr; 17(4):943-55. PubMed ID: 16540557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of endothelin with renal nerves modulates kidney function in spontaneously hypertensive rats.
    Girchev RA; Bäcker A; Markova PP; Kramer HJ
    Kidney Blood Press Res; 2006; 29(2):126-34. PubMed ID: 16864980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ET-1 actions in the kidney: evidence for sex differences.
    Kittikulsuth W; Sullivan JC; Pollock DM
    Br J Pharmacol; 2013 Jan; 168(2):318-26. PubMed ID: 22372527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel receptor antagonists welcome a new era in endothelin biology.
    Douglas SA; Meek TD; Ohlstein EH
    Trends Pharmacol Sci; 1994 Sep; 15(9):313-6. PubMed ID: 7992380
    [No Abstract]   [Full Text] [Related]  

  • 47. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chung TH; Lin SZ; Chang NC
    J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelin: a mediator of renal disease progression.
    Bruzzi I; Remuzzi G; Benigni A
    J Nephrol; 1997; 10(4):179-83. PubMed ID: 9377723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelin and endothelin antagonists in chronic kidney disease.
    Kohan DE; Barton M
    Kidney Int; 2014 Nov; 86(5):896-904. PubMed ID: 24805108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelin antagonists and renal protection.
    Benigni A; Perico N; Remuzzi G
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S75-78. PubMed ID: 10976787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of endothelin in cardiovascular disease.
    Agapitov AV; Haynes WG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal endothelin in hypertension.
    Pollock DM
    Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):157-64. PubMed ID: 10757221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of collecting duct endothelin in control of renal function and blood pressure.
    Kohan DE
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R659-68. PubMed ID: 23986358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of endothelin and hypertension in African-American individuals.
    Grubbs AL; Ergul A
    Ethn Dis; 2001; 11(4):741-8. PubMed ID: 11763297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of endothelin in hypertension.
    Rothermund L; Paul M
    Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):451-6. PubMed ID: 9690046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin-1 and the kidney--beyond BP.
    Dhaun N; Webb DJ; Kluth DC
    Br J Pharmacol; 2012 Oct; 167(4):720-31. PubMed ID: 22670597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelin in kidney disease.
    Nassar GM; Badr KF
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):86-91. PubMed ID: 7850416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of endothelin-1 in hypertension.
    Iglarz M; Schiffrin EL
    Curr Hypertens Rep; 2003 Apr; 5(2):144-8. PubMed ID: 12642014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An update.
    Blazek O; Bakris GL
    Eur J Pharmacol; 2024 Sep; 979():176752. PubMed ID: 39047966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelin, the kidney, and hypertension.
    Granger JP; Abram S; Stec D; Chandler D; LaMarca B
    Curr Hypertens Rep; 2006 Aug; 8(4):298-303. PubMed ID: 16884660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.